Skip to main content
G

Gameto

Gameto is a biotechnology company utilizing cell engineering to develop therapeutics for women's reproductive health, focusing on improving in vitro fertilization (IVF) and egg freezing processes. The company addresses significant gaps in fertility treatments and aims to enhance patient outcomes through its innovative platform.

East New York, United StatesFounded 20203910K+ followers
Updated 20 months ago

Funding

$75.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

TS
Funding rounds are not available yet.

Founders

Product

Problem

Current in vitro fertilization (IVF) and egg freezing processes have seen limited innovation in recent decades, resulting in suboptimal outcomes for women seeking reproductive assistance. These outdated methods often present significant gaps in treatment efficacy and patient satisfaction.

Solution

Gameto is a biotechnology company focused on developing cell-based therapeutics to address critical unmet needs in women's reproductive health, with an initial focus on improving IVF and egg freezing. The company's platform aims to enhance the quality and maturity of eggs through innovative cell engineering techniques. Their lead program, Fertilo, is designed to improve in vitro maturation (IVM), offering a potentially more effective and patient-friendly approach to fertility treatment. By advancing technology in a historically stagnant field, Gameto strives to provide women with better options and improved outcomes in their reproductive journeys.

Target Audience

Gameto's primary target audience includes women undergoing IVF or egg freezing, as well as fertility clinics seeking to improve patient outcomes and satisfaction.

Features

  • Development of Fertilo, a cell-based therapeutic to improve in vitro maturation (IVM) of eggs.
  • Focus on cell engineering to enhance egg quality and maturity.
  • Investigational studies to evaluate patient experience and satisfaction with Fertilo compared to conventional fertility stimulation.
  • Preclinical development partnerships with global fertility clinics.
  • Programs targeting a range of women's reproductive health needs, from infertility to menopause.
This profile is AI-generated and may contain inaccuracies.